Concepedia

A. Bardia

AB

2

Publications

66

Citations

2

H-Index

2022

Active since

Affiliations

Institut Curie(Current)

A. Bardia is an author at Institut Curie specializing in cancer therapeutics, radiation oncology, and breast cancer.

Top concepts

Publications per year

2022–2024

2

Publications

2

LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)

Hope S. Rugo, A. Bardia, F. Marmé et al. · Annals of Oncology · 2022 · 55 citations · Full text

, , +4

LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)

R.F. Salgado, A. Bardia, G. Curigliano et al. · Annals of Oncology · 2024 · 11 citations · Full text

Rows per page

1–2 of 2